2G0H | Transcription Activator | date | Feb 13, 2006 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
title | Structure-Based Drug Design Of A Novel Family Of Ppar Partia Agonists: Virtual Screening, X-Ray Crystallography And In V Vivo Biological Activities | ||||||||||||||
authors | I.L.Lu, Y.H.Peng, C.F.Huang, Y.T.Lin, J.T.A.Hsu, S.Y.Wu | ||||||||||||||
compound | source | ||||||||||||||
Molecule: Peroxisome Proliferator-Activated Receptor Gamma Chain: A, B Fragment: Ligand Binding Domain(Residues 207-477) Synonym: Ppar-Gamma Engineered: Yes |
Organism_scientific: Homo Sapiens Organism_common: Human Organism_taxid: 9606 Gene: Pparg, Nr1c3 Expression_system: Escherichia Coli Bl21(De3) Expression_system_taxid: 469008 Expression_system_strain: Bl21(De3) Expression_system_vector_type: Plasmid Expression_system_plasmid: Pgex6p-1 | ||||||||||||||
symmetry | Space Group: P 1 21 1 |
| |||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 2.30 Å | ||||||||||||
ligand | SP3 BindingDB | enzyme |
| ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Structure-based drug design of a novel family of PPARgamma partial agonists: virtual screening, X-ray crystallography, and in vitro/in vivo biological activities., Lu IL, Huang CF, Peng YH, Lin YT, Hsieh HP, Chen CT, Lien TW, Lee HJ, Mahindroo N, Prakash E, Yueh A, Chen HY, Goparaju CM, Chen X, Liao CC, Chao YS, Hsu JT, Wu SY, J Med Chem. 2006 May 4;49(9):2703-12. PMID:16640330 |
Data retrieval |
View 2G0H in 3D |
Visual 3D analysis of 2G0H |
Structure-derived information |
Sequence-derived information |
Other resources with information on 2G0H |
Movements, Movies and Images |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |